• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

The Role of Private Label Agreements in Enhancing Access to Biosimilars

Opinion
Video

Panelists discuss how private label agreements facilitate biosimilar market entry by allowing manufacturers to collaborate on branding, distribution, and market access, ultimately expanding treatment options and potentially reducing health care costs.

Related Videos
Dr Elise Tremblay
4 experts in this video
4 experts in this video
Dr Carla Nester
AJMC interview with Ali Shan Hafeez and Dr Abdul Rafae Faisal | Background image credit: ipopba - stock.adobe.com
Dr Carla Nester
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.